⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001842129

Foy Matthew

Reports to the SEC for 1 company · BOSTON, MA

Transactions

8

Companies

1

Filings

2

CIK

0001842129

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-17	Decibel Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+458K sh	—	—	458,487
2021-02-17	Decibel Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+247K sh	—	—	705,811
2021-02-17	Decibel Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+328K sh	—	—	1,033,663
2021-02-17	Decibel Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+150K sh	$18.00	+$2.7M	1,183,663
2021-02-17	Decibel Therapeutics, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−7.12M sh	—	—	0
2021-02-17	Decibel Therapeutics, Inc.Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.13M sh	—	—	0
2021-02-17	Decibel Therapeutics, Inc.Series D Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.74M sh	—	—	0
2021-02-11	Decibel Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000

Recent filings

2

Accepted (ET)
Feb 194
Foy Matthew0000899243-21-007444
SEC(opens sec.gov)
Feb 164
Foy Matthew0000899243-21-006704
SEC(opens sec.gov)

Companies

1

Decibel Therapeutics, Inc.Director, 10% Owner

Address

C/O DECIBEL THERAPEUTICS, INC. 1325 BOYLSTON STREET, SUITE 500

BOSTON, MA, 02215